Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine: Evidence from a Therapeutic Drug Monitoring Service

@article{Jerling1994FluvoxamineIA,
  title={Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine: Evidence from a Therapeutic Drug Monitoring Service},
  author={Markus Jerling and Leif H. Lindstr{\"o}m and U. G. Bondesson and Leif Bertilsson},
  journal={Therapeutic Drug Monitoring},
  year={1994},
  volume={16},
  pages={368–374}
}
Therapeutic drug monitoring data for clozapine were used to study interactions with other drugs. The distribution of the ratio concentration/dose (C/D) of clozapine was compared in four matched groups—patients simultaneously treated with benzodiazepines, patients on drugs that inhibit the cytochrome P450 enzyme CYP2D6, patients taking carbamazepine, and those not taking any of these drugs. No difference was seen among the monotherapy, CYP2D6, and benzodiazepine groups. Patients on carbamazepine… 

Fluvoxamine But Not Sertraline Inhibits the Metabolism of Olanzapine: Evidence From A Therapeutic Drug Monitoring Service

Therapeutic drug monitoring data indicated that fluvoxamine inhibits the metabolism of olanzapine, probably because of inhibition of cytochrome P450 (CYP1A2) 1A2, whereas sertraline is unlikely to interfere with the metabolismOf course, combination therapy of Olanz Zapine and fluv oxamine should be used cautiously, and therapeutic drug monitoring should be instituted to avoid olanZapine-induced adverse effects or intoxications.

Clinically Significant Pharmacokinetic Drug Interactions with Carbamazepine

Avoidance of unnecessary polypharmacy, selection of alternative agents with lower interaction potential, and careful dosage adjustments based on serum drug concentration monitoring and clinical observation represent the mainstays for the minimisation of risks associated with these interactions.

Fluvoxamine-Clozapine drug interaction: inhibition in vitro of five cytochrome P450 isoforms involved in clozapine metabolism.

In a human liver microsome preparation, fluvoxamine showed a concentration-dependent inhibition of clozapine N-demethylation and inhibition of all but CYP3A4 of the five cytochrome P450 isoforms previously determined to be capable of catalyzing the demethylation of clazapine.

Complex drug interaction of carbamazepine, fluvoxamine and clozapine in a patient with bipolar depression

This case highlights the importance of monitoring plasma concentrations or clinical status when multiple drugs that inhibit or inhibit CYP450 are combined, and suggests that the effect of FVX on CLZ was much greater than that of CBZ onCLZ, which would reduce the dose of CLZ required in this patient.

The Differential Effects of Steady‐State Fluvoxamine on the Pharmacokinetics of Olanzapine and Clozapine in Healthy Volunteers

The effects of fluvoxamine on different aspects of pharmacokinetics of the two antipsychotics may have implications for clinical therapeutics.

Clinical Significance of Pharmacokinetic Interactions Between Antiepileptic and Psychotropic Drugs

Serum level monitoring of AEDs and psychotropic drugs can be useful in determining the need for dosage adjustments, especially if there is any change in seizure control, or possible toxicity, as well as predicting and avoiding clinically significant interactions.

Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.

In all patients, fluvoxamine induced relevant increases in serum concentrations ofClozapine and its metabolites, probably by the inhibition of enzymes catalyzing the degradation of clozapines and N-desmethylclozabine, whereas paroxetine, at a usual clinically effective dosage of 20 mg/day, did not cause significant pharmacokinetic interactions.

A pharmacokinetic interaction between carbamazepine and olanzapine: observations on possible mechanism

Olanzapine is a novel antipsychotic, which is effective against both the positive and negative symptoms of schizophrenia and causes fewer extrapyramidal adverse effects than conventional antipsychotics, and carbamazepine has been shown to induce several P450 cytochromes including CYP3A4 and CYP1A2.

Effects of carbamazepine coadministration on plasma concentrations of the enantiomers of mianserin and of its metabolites.

The results strongly suggest the involvement of CYP3A4, the major CYP enzyme induced by carbamazepine, in the metabolism of both enantiomers of mianserin.

Interactions between Antiepileptic and Antipsychotic Drugs

A review of human clinical data on the interactions between the antiepileptic drugs carbamazepine, valproic acid (sodium valproate), vigabatrin, lamotrigine, gabapentin, topiramate, tiagabine, oxcarbazepines, levetiracetam, pregabalin, felbamate, zonisamide, phenobarbital and phenytoin is presented.
...